95 filings
Page 2 of 5
SC14D9C
dg6j66n4
1 Sep 22
Written communication relating to third party tender offer
9:14am
8-K
emdffd5yafk h2u
1 Sep 22
Tender and Support Agreement
8:55am
S-8
6r5g4aaf
5 Aug 22
Registration of securities for employees
4:49pm
8-K
0wjsr 9u8r6te9hzlx
5 Aug 22
Forma Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
7:30am
8-K
x038uhopf
25 Jul 22
Departure of Directors or Certain Officers
4:30pm
8-K
01x zffe4jq
9 Jun 22
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
6nkues5kcclcaed
26 May 22
Regulation FD Disclosure
7:30am
8-K
8f9nu msid
6 May 22
Forma Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
7:31am
EFFECT
5kr2pj37lrthog
4 May 22
Notice of effectiveness
12:15am
DEFA14A
rjg7n mzc4dbqy
27 Apr 22
Additional proxy soliciting materials
4:05pm
S-8
7b9ewx9rad7jo9c5m x3
2 Mar 22
Registration of securities for employees
6:11am
POS AM
5ruwa8l5551a
1 Mar 22
Prospectus update (post-effective amendment)
9:58pm
POSASR
uev62807
1 Mar 22
Automatic shelf registration (post-effective amendment)
4:02pm
8-K
wgar09q87 ylp2
1 Mar 22
Forma Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results and Provides Business Update
7:31am
8-K
nyey75an9ms7k02c65t
13 Jan 22
Departure of Directors or Certain Officers
7:23am
8-K
mh3akn
16 Dec 21
First Phase 2 combination trial results presented in oral session at 2021 ASH Annual Meeting
7:13am